Emergent BioSolutions EBS
NYSE EBS
$6.22 +0.02 (+0.32%)
At close: Oct 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Depreciation and Depletion (2021 - 2026)

Updated

Emergent BioSolutions (EBS) posted Depreciation and Depletion of $6.8 million for Q2 2026, down 6.8% from $7.3 million a year earlier and down 2.9% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Depreciation and Depletion (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation and Depletion at Emergent BioSolutions was $28.1 million, down 22.4% year-over-year; for FY2025, it was $30.7 million, down 29.7% from FY2024.

  • Annual Depreciation and Depletion has declined for three consecutive years, with a five-year compound annual growth rate of -9.3% (FY2020 to FY2025).
  • In prior years, Emergent BioSolutions' Depreciation and Depletion was $43.7 million in FY2024 (-26.6%), $59.5 million in FY2023 (-28.7%), $83.4 million in FY2022 (+34.1%) and $62.2 million in FY2021 (+24.2%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation and Depletion in data going back to Q1 2021.
  • On a year-over-year basis, Depreciation and Depletion has declined in each of the last 13 quarters, with an average decline of 23.6% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation and Depletion in the past five years was Q2 2022, with growth of 54.1%; the weakest was Q3 2023, with a decline of 42.4%.
  • According to Business Quant data, Depreciation and Depletion for the three prior quarters was $7 million (Q1 2026), $7.2 million (Q4 2025) and $7.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Emergent BioSolutions 319.09 Mn -431.81 Mn 137.20 Mn 6.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.80 Mn
Mar 31, 2026 7.00 Mn
Dec 31, 2025 7.20 Mn
Sep 30, 2025 7.10 Mn
Jun 30, 2025 7.30 Mn
Mar 31, 2025 9.10 Mn
Dec 31, 2024 9.70 Mn
Sep 30, 2024 10.10 Mn
Jun 30, 2024 12.20 Mn
Mar 31, 2024 11.70 Mn
Dec 31, 2023 13.40 Mn
Sep 30, 2023 11.70 Mn
Jun 30, 2023 16.80 Mn
Mar 31, 2023 17.60 Mn
Dec 31, 2022 18.00 Mn
Sep 30, 2022 20.30 Mn
Jun 30, 2022 28.50 Mn
Mar 31, 2022 16.60 Mn
Dec 31, 2021 15.70 Mn
Sep 30, 2021 14.40 Mn
API Access

Emergent BioSolutions Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=EBS&period=max&api_key=YOUR_API_KEY